Evidence map›Paper›PMID 30664281›Full record

ArticleEuropean journal of haematology2019

Single versus double-unit transfusion: Safety and efficacy for patients with hematologic malignancies.

Zelia Bowman, Naomi Fei, Janice Ahn, Sijin Wen, Aaron Cumpston, Nilay Shah, Michael Craig, Peter L Perrotta, Abraham S Kanate

Abstract read
In one paragraph

Article in European journal of haematology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zelia BowmanDepartment of Hematology/Oncology, West Virginia University, Morgantown, West Virginia.ORCID https://orcid.org/0000-0002-1855-4701
Naomi FeiDepartment of Hematology/Oncology, West Virginia University, Morgantown, West Virginia.ORCID https://orcid.org/0000-0001-9278-3521
Janice AhnDepartment of Pathology, West Virginia University, Morgantown, West Virginia.
Sijin WenDepartment of Biostatistics, School of Public Health, West Virginia University, Morgantown, West Virginia.
Aaron CumpstonDepartment of Pharmacy, West Virginia University Hospitals, Morgantown, West Virginia.
Nilay ShahAlexander B. Osborn Hematopoietic Malignancy and Transplantation Program, West Virginia University, Morgantown, West Virginia.
Michael CraigAlexander B. Osborn Hematopoietic Malignancy and Transplantation Program, West Virginia University, Morgantown, West Virginia.
Peter L PerrottaDepartment of Pathology, West Virginia University, Morgantown, West Virginia.
Abraham S KanateAlexander B. Osborn Hematopoietic Malignancy and Transplantation Program, West Virginia University, Morgantown, West Virginia.

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Sally Lynn Hodder · 2012 to 2026
$81.0M
NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

objectivesAlthough hemoglobin thresholds for red blood cell (RBC) transfusion have decreased, double-unit RBC transfusion practices persist. We studied the effects switching from predominantly double-unit to single-unit RBC transfusions had on utilization and clinical outcomes for malignant hematology patients.

methodsRetrospective chart review compared malignant hematology patients before and after implementing single-unit RBC transfusion policy. Hemoglobin threshold was 8.0 g/dL for both groups. RBC utilization metrics included number of RBC units transfused, RBC units transfused per admission, and number of transfusion episodes. Clinical outcomes included length of stay, 30-day mortality, and outpatient RBC transfusion 30-days post-discharge.

resultsBaseline hemoglobin was similar in both groups. The single-unit group was transfused with fewer RBC units per admission (5.1 vs 4.5, P = 0.01) than the double-unit group, but had more transfusion episodes per admission (4.1 vs 2.7, P < 0.001). After implementing single-unit policy, a 29% reduction in RBC utilization was observed. Mean hemoglobin at discharge was lower in the single-unit group (8.9 vs 9.5 g/dL, P = 0.005). No significant differences in length of stay or 30-day mortality were observed.

conclusionTransfusing malignant hematology patients with single RBC units is safe and efficacious. Electronic provider order systems facilitating RBC transfusion requests provide excellent adherence to transfusion policy.

Indexed as

Blood TransfusionAdultAgedCombined Modality TherapyDisease ManagementErythrocyte IndicesErythrocyte TransfusionFemaleHematologic NeoplasmsHumansMaleMiddle AgedTransfusion ReactionTreatment OutcomeBlooddoubleerythrocytehematologyred blood cellsingletransfusionunit

Identifiers

PMID30664281
PMCPMC6542263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.